From NICU to toddlerhood: Austin clinic supports premature babies’ first years

Dell Children’s doctors track development, offer therapy and study which NICU treatments lead to the best long-term outcomes.

iECURE, Inc.: iECURE to Present OTC-HOPE Clinical Trial Data of ECUR-506 in Ornithine Transcarbamylase Deficiency at the European Society of Gene & Cell Therapy Annual Congress ...

ECURE, Inc., a genome editing company focused on the development of variant-agnostic in vivo targeted gene insertion therapies for the treatment of liver disorders with significant unmet need, today ...